We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors

By LabMedica International staff writers
Posted on 27 Jul 2023

Many institutions grapple with the issue of excess hemolyzed samples and are keen to understand how to address this problem while preserving scarce resources. More...

The AACC session titled "Data Analytics Competition: Forecasting Future Preanalytical Errors" focused on this very issue.

At the session, Mark Zaydman, MD, Ph.D., from Washington University in St. Louis (WUSTL, St. Louis, MO, USA) announced the winners of a unique competition focused on utilizing data science to predict preanalytical errors arising from incorrect blood specimen collection. The session highlighted the lessons that medical lab professionals could learn from this competition. Co-hosted by the Section of Pathology Informatics of Washington University in St. Louis and the ADLM Data Analytics Steering Committee, the competition used a machine-learning and data-science platform called Kaggle to crowdsource solutions for problems across disciplines.

The competition for this year, titled "Help with Hemolysis," provided a real-world, anonymized dataset reflecting hemolysis within the clinical lab. Contestants had to use this dataset to determine which blood-specimen collectors could gain the most from training in phlebotomy best practices. The idea was to discover ways to reduce in vitro hemolysis while effectively using laboratory time and resources. The winning solution could guide institutions on how to better allocate their training resources. While educational interventions can help reduce hemolysis, they can be expensive and temporary, especially with a high staff turnover. A total of 18 participating teams had slightly over a month to work with the provided dataset before submitting their solution and also had to submit their code to demonstrate their problem-solving approach.

After providing an overview of the competition and summarizing the strategies adopted by the teams, Zaydman announced the winning team—Team Hemolyers. The winning team then shared their solution, offering attendees the opportunity to learn more about them, their approach to the problem, and ask any questions. The session's innovative teaching style differed from the conventional lecture format, aiming to cater to individuals of varying levels of experience. The format of the competition, which is into its second year, provided a novel way to learn, foster a collaborative community, and discover powerful solutions for real-world problems. Zaydman who had hosted the first competition as well pointed out that interdisciplinary teams—combining clinical lab expertise and computer-science knowledge—had been the winners both the times. This was mainly attributed to the increasing accessibility of data science tools and computational resources to individuals without advanced data science degrees. Such interdisciplinary teams can identify gaps in patient care and collaborate to develop innovative and viable solutions.

Despite the particular difficulty of the task for this year's competition, Zaydman stressed that the results were remarkable. “A valuable model doesn’t have to be perfect, as long as it saves costs and improves patient care,” he said.

Related Links:
WUSTL


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.